These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Medullary thyroid carcinoma in children]. Berdelou A; Hartl D; Al Ghuzlan A; Mirghani H; Chougnet C; Baudin E; Schlumberger M; Leboulleux S Bull Cancer; 2013; 100(7-8):780-8. PubMed ID: 23831771 [TBL] [Abstract][Full Text] [Related]
23. Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II. Ledger GA; Khosla S; Lindor NM; Thibodeau SN; Gharib H Ann Intern Med; 1995 Jan; 122(2):118-24. PubMed ID: 7992986 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic and therapeutic aspects in medullary thyroid carcinoma. Safioleas M; Stamatakos M; Karampali E; Rompoti N; Mouzopoulos G; Lygidakis N Chirurgia (Bucur); 2006; 101(2):121-6. PubMed ID: 16752676 [TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of medullary thyroid carcinoma: current approaches in diagnosis and treatment. Boikos SA; Stratakis CA Histol Histopathol; 2008 Jan; 23(1):109-16. PubMed ID: 17952863 [TBL] [Abstract][Full Text] [Related]
28. Medullary carcinoma of the thyroid gland. Wells SA; Franz C World J Surg; 2000 Aug; 24(8):952-6. PubMed ID: 10865039 [TBL] [Abstract][Full Text] [Related]
29. Medullary Thyroid Carcinoma Associated with Germline RET Xu JY; Grubbs EG; Waguespack SG; Jimenez C; Gagel RF; Sosa JA; Sellin RV; Dadu R; Hu MI; Trotter CS; Jackson M; Rich TA; Hyde SM; Sherman SI; Cote GJ Thyroid; 2016 Dec; 26(12):1744-1751. PubMed ID: 27673361 [TBL] [Abstract][Full Text] [Related]
30. Current management of medullary thyroid cancer. Sippel RS; Kunnimalaiyaan M; Chen H Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739 [TBL] [Abstract][Full Text] [Related]
31. [Medullary thyroid cancer - the present state of art]. Krysiak R; Marek B; Okopień B Endokrynol Pol; 2008; 59(5):446-55. PubMed ID: 18979455 [TBL] [Abstract][Full Text] [Related]
32. [The treatment of medullary thyroid cancer]. Fujita T; Fujimori M Gan To Kagaku Ryoho; 2009 Oct; 36(10):1627-31. PubMed ID: 19838021 [TBL] [Abstract][Full Text] [Related]
35. Management of medullary thyroid carcinoma. Jiménez C; Hu MI; Gagel RF Endocrinol Metab Clin North Am; 2008 Jun; 37(2):481-96, x-xi. PubMed ID: 18502338 [TBL] [Abstract][Full Text] [Related]
36. Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey. Aydoğan Bİ; Yüksel B; Tuna MM; Navdar Başaran M; Akkurt Kocaeli A; Ertörer ME; Aydın K; Güldiken S; Şimşek Y; Cihan Karaca Z; Yılmaz M; Aktürk M; Anaforoğlu İ; Kebapçı N; Duran C; Taşlıpınar A; Kulaksızoğlu M; Gürsoy A; Dağdelen S; Erdoğan MF J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):13-20. PubMed ID: 26758973 [TBL] [Abstract][Full Text] [Related]
37. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation. Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606 [TBL] [Abstract][Full Text] [Related]
40. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]